FDA Drug Recalls

Recalls / Class II

Class IID-205-2013

Product

ZARAH¿ Drospirenone/ Ethinyl Estradiol Tablets, 3.0 mg/0.03 mg, Rx only, 3 tablet dispensers, 28 tablets each, Manuf. by: Watson Laboratories, Inc., Corona, CA 92880. USA; Distributed by: Watson Pharma, Inc., Corona, CA 92880 USA. NDC 52544-981-31 Carton; NDC 52544-981-28

Affected lot / code info
Lot #s: 401536AA/401536A; 401537AA/401537/A; 401538AA/401538/A; 406985AA/406985A; 432058AA/432058A; 512685AA/512685A

Why it was recalled

Failed Tablet/Capsule Specification; tablet breakage while pushing through the blister pack (dispenser) .

Recalling firm

Firm
Watson Laboratories Inc
Notification channel
Letter
Type
Voluntary: Firm initiated
Address
311 Bonnie Cir, N/A, Corona, California 92880-2882

Distribution

Quantity
136,720 cartons
Distribution pattern
Nationwide

Timeline

Recall initiated
2013-02-13
FDA classified
2013-03-19
Posted by FDA
2013-03-27
Terminated
2014-01-31
Status
Terminated

Source: openFDA Drug Enforcement endpoint. Recall record D-205-2013. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.

Class II recall: drug · FDA Drug Recalls